Abstract
We sought to assess the sex- and age-specific trends in venous thromboembolism (VTE) mortality in the 27 European Union Member States (EU-27) between years 2012 and 2020. Data on cause-specific deaths and population numbers by sex for each country of the EU-27 were retrieved through the publicly available European Statistical Office (EUROSTAT) dataset for the years 2012–2020. VTE-related deaths were ascertained when ICD-10 codes I26, I80, and I82.9 were listed as the primary cause of death in the medical death certificate. To calculate annual trends, we assessed the average annual percent change (AAPC) with relative 95% confidence intervals (CIs) using Joinpoint regression. During the study period, 96,037 (55,278 males and 40,759 females) died for VTE. The age-adjusted mortality rate (AAMR) linearly declined from 2.86 (95% CI 2.84–2.90) deaths per 100,000 individuals in 2012 to 2.53 (95% CI 2.50–2.56) deaths per 100,000 population in 2020 [AAPC: – 2.1% (95% CI – 3.6 to – 0.6), p = 0.001] without differences between sexes (p = 0.60). The higher AAMR was observed in some eastern European countries such as Bulgaria, Czech Republic, and Lithuania. On the contrary, the lower AAMR was mainly clustered in the Mediterranean area (Italy, Spain, and Cyprus). Over the last decade, the age-adjusted VTE-related mortality has been continuously declining in most of the in EU-27 Member States. However, some disparities still exist between western and eastern European countries.
Similar content being viewed by others
Data availability
The data underlying this article are freely available from the EUROSTAT dataset at https://ec.europa.eu/eurostat/data/database
Abbreviations
- AAMR:
-
Age-adjusted mortality rate
- AAPC:
-
Average annual percent change
- APC:
-
Annual percent change
- CI:
-
Confidence interval
- EUROSTAT:
-
European Statistical Office
- PE:
-
Pulmonary embolism
- VTE:
-
Venous thromboembolism
References
Glynn RJ, Rosner B (2005) Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 162:975–982
Cohen AT, Agnelli G, Anderson FA et al (2007) Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 98:756–764
Heit JA (2008) The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 28:370–372
Lutsey PL, Zakai NA (2023) Epidemiology and prevention of venous thromboembolism. Nat Rev Cardiol 20:248–262
Keller K, Hobohm L, Ebner M, Kresoja KP, Münzel T, Konstantinides SV, Lankeit M (2020) Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J 41:522–529
Willich SN, Chuang LH, van Hout B, Gumbs P, Jimenez D, Kroep S, Bauersachs R, Monreal M, Agnelli G, Cohen A (2018) Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work. Thromb Res 170:181–191
Balachandran A, de Beer J, James KS, van Wissen L, Janssen F (2020) Comparison of population aging in europe and asia using a time-consistent and comparative aging measure. J Aging Health 32:340–351
Engbers MJ, van Hylckama VA, Rosendaal FR (2010) Venous thrombosis in the elderly: incidence, risk factors and risk groups. J Thromb Haemost 8:2105–2112
Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, Gavin A, Flego M, Neamtiu L, Dimitrova N, Negrão Carvalho R, Ferlay J, Bettio M (2021) The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer 157:308–347
Berghöfer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN (2008) Obesity prevalence from a European perspective: a systematic review. BMC Public Health 8:200
Willame C, Dodd C, van der Aa L, Picelli G, Emborg HD, Kahlert J, Gini R, Huerta C, Martín-Merino E, McGee C, de Lusignan S, Roberto G, Villa M, Weibel D, Titievsky L, Sturkenboom MCJM (2021) Incidence rates of autoimmune diseases in european healthcare databases: a contribution of the ADVANCE project. Drug Saf 44:383–395
Khialani D, Jones ME, Szépligeti SK, Ording AG, Ehrenstein V, Petersen I, van Hylckama VA (2020) Combined hormonal contraceptive use in Europe before and after the European Commission mandated changes in product information. Contracept X 2:100018
Barco S, Mahmoudpour SH, Valerio L, Klok FA, Münzel T, Middeldorp S, Ageno W, Cohen AT, Hunt BJ, Konstantinides SV (2020) Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med 8:277–287
Barco S, Valerio L, Gallo A, Turatti G, Mahmoudpour SH, Ageno W, Castellucci LA, Cesarman-Maus G, Ddungu H, De Paula EV, Dumantepe M, Goldhaber SZ, Guillermo Esposito MC, Klok FA, Kucher N, McLintock C, Ní Áinle F, Simioni P, Spirk D, Spyropoulos AC, Urano T, Zhai ZG, Hunt BJ, Konstantinides SV (2021) Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries. Res Pract Thromb Haemost 5:e12520
https://ec.europa.eu/eurostat/data/database [Accessed 14 March 2023]
https://ec.europa.eu/eurostat/cache/metadata/en/demo_mor_esms.htm [Accessed 14 March 2023]
https://ec.europa.eu/eurostat/web/products-manuals-and-guidelines/-/ks-ra-13-028 [Accessed 14 March 2023]
Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M, Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35:3033–69
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, Huisman MV, Humbert M, Jennings CS, Jiménez D, Kucher N, Lang IM, Lankeit M, Lorusso R, Mazzolai L, Meneveau N, Ní Áinle F, Prandoni P, Pruszczyk P, Righini M, Torbicki A, Van Belle E, Zamorano JL, Van Belle E, Zamorano JL; ESC Scientific Document Group (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603
National Cancer Institute. Number of Joipoints. Available at: https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/number-of-joinpoints [Accessed March 29,2023]
Kim HJ, Fay MP, Yu B, Barrett MJ, Feuer EJ (2004) Comparability of segmented line regression models. Biometrics 60:1005–1014
Weitz JI, Chan NC (2020) Novel antithrombotic strategies for treatment of venous thromboembolism. Blood 135:351–359
Elmi G, Pizzini AM, Silingardi M (2018) The secondary prevention of venous thromboembolism: towards an individual therapeutic strategy. Vascular 26:670–682
Di Fazio N, Delogu G, Ciallella C, Padovano M, Spadazzi F, Frati P, Fineschi V (2021) State-of-art in the age determination of venous thromboembolism: a systematic review. Diagnostics (Basel) 11:2397
Farge D, Frere C, Connors JM, Khorana AA, Kakkar A, Ay C, Muñoz A, Brenner B, Prata PH, Brilhante D, Antic D, Casais P, Guillermo Esposito MC, Ikezoe T, Abutalib SA, Meillon-García LA, Bounameaux H, Pabinger I, Douketis J, International Initiative on Thrombosis and Cancer (ITAC) advisory panel (2022) 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol 23:e334–e347
Duranteau J, Taccone FS, Verhamme P, Ageno W, ESA VTE Guidelines Task Force (2018) European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care. Eur J Anaesthesiol 35:142–146
Van Es N, van der Hulle T, van Es J, den Exter PL, Douma RA, Goekoop RJ, Mos IC, Galipienzo J, Kamphuisen PW, Huisman MV et al (2016) Wells rule and D-dimer testing to rule out pulmonary embolism: a systematic review and individual-patient data meta-analysis. Ann Intern Med 165:253–261
Righini M, Robert-Ebadi H, Le Gal G (2017) Diagnosis of acute pulmonary embolism. J Thromb Haemost 15:1251–1261
Heit JA (2015) Epidemiology of venous thromboembolism. Nat Rev Cardiol 12:464–474
Santucci C, Patel L, Malvezzi M, Wojtyla C, La Vecchia C, Negri E, Bertuccio P (2022) Persisting cancer mortality gap between western and eastern Europe. Eur J Cancer 165:1–12
Lind MM, Johansson M, Själander A, Johansson L (2022) Incidence and risk factors of venous thromboembolism in men and women. Thromb Res 214:82–86
Cushman M, Tsai AW, White RH, Heckbert SR, Rosamond WD, Enright P et al (2004) Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med 117:19–25
Severinsen MT, Johnsen SP, Tjønneland A, Overvad K, Dethlefsen C, Kristensen SR (2010) Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med 21:268–272
Loichinger E, Weber D (2016) Trends in working life expectancy in Europe. J Aging Health 28:1194–1213
Arnesen CAL, Veres K, Horváth-Puhó E, Hansen JB, Sørensen HT, Brækkan SK (2022) Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death. Eur J Epidemiol 37:195–203
Marshall AL, Bartley AC, Ashrani AA, Pruthi RK, Durani U, Gonsalves WI, Kapoor P, Hashmi SK, Siddiqui MA, Go RS (2017) Sex-based disparities in venous thromboembolism outcomes: a National Inpatient Sample (NIS)-based analysis. Vasc Med 22:121–127
Giannis D, Barish MA, Goldin M, Cohen SL, Kohn N, Gianos E, Chatterjee S, Lesser M, Coppa K, Hirsch JS, McGinn T, Spyropoulos AC, COVID-19 Consortium Group (2021) Incidence of venous thromboembolism and mortality in patients with initial presentation of COVID-19. J Thromb Thrombolysis 51:897–901
Zuin M, Barco S, Giannakoulas G, Engelen MM, Hobohm L, Valerio L, Vandenbriele C, Verhamme P, Vanassche T, Konstantinides SV (2023) Risk of venous thromboembolic events after COVID-19 infection: a systematic review and meta-analysis. J Thromb Thrombolysis 55:490–498
Fang MC, Reynolds K, Tabada GH, Prasad PA, Sung SH, Parks AL, Garcia E, Portugal C, Fan D, Pai AP, Go AS (2023) Assessment of the risk of venous thromboembolism in nonhospitalized patients with COVID-19. JAMA Netw Open 6:e232338
Öhman L, Johansson M, Jansson JH, Lind M, Johansson L (2018) Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries. Clin Epidemiol 10:1215–1221
Burles K, Innes G, Senior K, Lang E, McRae A (2017) Limitations of pulmonary embolism ICD-10 codes in emergency department administrative data: let the buyer beware. BMC Med Res Methodol 17:89
White RH, Garcia M, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, Sama P, Gammon H, Schmaltz S, Romano PS (2010) Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res 126:61–67
Lloyd-Jones DM, Martin DO, Larson MG, Levy D (1998) Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med 129:1020–1026
Acknowledgements
None.
Funding
None.
Author information
Authors and Affiliations
Contributions
Concept and design: MZ and CB. Acquisition, analysis, and interpretation of data: MZ, GR, PLT, and CB. Drafting and writing of the manuscript: MZ and GR. Review and editing: CB and PLT. All authors have read and approved the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest to disclose statement.
Ethical approval
The study did not require institutional review board approval since the analysis was based on de-identified and publicly available data.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zuin, M., Rigatelli, G., Temporelli, P. et al. Trends in mortality related to venous thromboembolism in the European Union, 2012–2020. Intern Emerg Med (2024). https://doi.org/10.1007/s11739-024-03550-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11739-024-03550-6